Allurion Technologies Inc
Company Profile
Business description
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world’s first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
Contact
11 Huron Drive
NatickMA01760
USAT: +1 508 647-4000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
137
Stocks News & Analysis
stocks
Ask the analyst: Are markets missing something with CSL?
stocks
This ASX stock’s bubble has well and truly burst
stocks
Tesla’s stock is in trouble, but this fund manager sees a comeback in 2026
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,215.30 | 13.20 | -0.14% |
CAC 40 | 7,709.81 | 133.23 | -1.70% |
DAX 40 | 24,152.87 | 120.25 | -0.50% |
Dow JONES (US) | 45,418.07 | 135.60 | 0.30% |
FTSE 100 | 9,265.80 | 55.60 | -0.60% |
HKSE | 25,541.43 | 16.51 | 0.06% |
NASDAQ | 21,544.27 | 94.98 | 0.44% |
Nikkei 225 | 42,501.93 | 107.53 | 0.25% |
NZX 50 Index | 12,875.80 | 82.18 | -0.63% |
S&P 500 | 6,465.94 | 26.62 | 0.41% |
S&P/ASX 200 | 8,949.00 | 12.20 | -0.14% |
SSE Composite Index | 3,881.07 | 12.69 | 0.33% |